Literature DB >> 18625101

Intrathecal analgesia for refractory cancer pain.

Scott Newsome1, Bridget K Frawley, Charles E Argoff.   

Abstract

The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18625101     DOI： 10.1007/s11916-008-0043-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  51 in total

1.  Intrathecal infusion therapy with dexmedetomidine-supplemented morphine in cancer pain.

Authors:  F Ugur; N Gulcu; A Boyaci
Journal:  Acta Anaesthesiol Scand       Date:  2006-12-04       Impact factor: 2.105

2.  Intrathecal betamethasone for cancer pain in the lower half of the body: a study of its analgesic efficacy and safety.

Authors:  H Taguchi; K Oishi; S Sakamoto; K Shingu
Journal:  Br J Anaesth       Date:  2007-01-16       Impact factor: 9.166

3.  Intrathecal ropivacaine in cancer pain.

Authors:  S Mercadante; L Calderone; L Barresi
Journal:  Reg Anesth Pain Med       Date:  1998 Nov-Dec       Impact factor: 6.288

Review 4.  Clinical realities and economic considerations: efficacy of intrathecal pain therapy.

Authors:  J A Paice; W Winkelmüller; K Burchiel; G B Racz; J P Prager
Journal:  J Pain Symptom Manage       Date:  1997-09       Impact factor: 3.612

5.  Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain.

Authors:  P Nitescu; L Appelgren; L E Linder; M Sjöberg; E Hultman; I Curelaru
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612

6.  Intrathecal morphine for neuropathic pain in a pregnant cancer patient.

Authors:  Y R Wen; W Y Hou; Y A Chen; C Y Hsieh; W Z Sun
Journal:  J Formos Med Assoc       Date:  1996-03       Impact factor: 3.282

Review 7.  Neuraxial techniques for cancer pain: an opinion about unresolved therapeutic dilemmas.

Authors:  S Mercadante
Journal:  Reg Anesth Pain Med       Date:  1999 Jan-Feb       Impact factor: 6.288

8.  Treatment of neuropathic cancer pain with continuous intrathecal administration of S +-ketamine.

Authors:  J H Vranken; M H van der Vegt; J E Kal; M R Kruis
Journal:  Acta Anaesthesiol Scand       Date:  2004-02       Impact factor: 2.105

Review 9.  Neuraxial pain relief for intractable cancer pain.

Authors:  Paul A Sloan
Journal:  Curr Pain Headache Rep       Date:  2007-08

Review 10.  Neuraxial infusion in patients with chronic intractable cancer and noncancer pain.

Authors:  R K Osenbach; S Harvey
Journal:  Curr Pain Headache Rep       Date:  2001-06
View more
  7 in total

Review 1.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Palliative CT-Guided Cordotomy for Medically Intractable Pain in Patients with Cancer.

Authors:  T M Shepherd; M J Hoch; B A Cohen; M T Bruno; E Fieremans; G Rosen; D Pacione; A Y Mogilner
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

Review 3.  Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome.

Authors:  Francesca Pistoia; Simona Sacco; Marco Sarà; Marco Franceschini; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2015-01

4.  Total pancreatectomy with islet cell transplantation vs intrathecal narcotic pump infusion for pain control in chronic pancreatitis.

Authors:  Mohamad Mokadem; Lama Noureddine; Thomas Howard; Lee McHenry; Stuart Sherman; Evan L Fogel; James L Watkins; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 5.  Intrathecal Therapy for Cancer-Related Pain.

Authors:  Brian M Bruel; Allen W Burton
Journal:  Pain Med       Date:  2016-04-28       Impact factor: 3.750

6.  Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study.

Authors:  Shuyue Zheng; Liangliang He; Xiaohui Yang; Xiuhua Li; Zhanmin Yang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 7.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.